EMJ GOLD

For pharma, building an ERG can be essential for inclusivity. Find out how to create a great one with these top tips.

Christi Shaw, former CEO, Kite Pharma, shares her thoughts on improving access to cell therapies and her motivations for working in oncology

Exploring the current state of the US pharmaceutical market, this article investigates the balance between innovation and access to care in the country.

Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.

Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.

The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?

AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.